<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-BE7XMZOQ</identifier><date>2013</date><creator>Fic, Anja</creator><creator>Peterlin-Mašič, Lucija</creator><creator>Sollner Dolenc, Marija</creator><relation>documents/doc/B/URN_NBN_SI_doc-BE7XMZOQ_001.htm</relation><relation>documents/doc/B/URN_NBN_SI_doc-BE7XMZOQ_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BE7XMZOQ_001.txt</relation><format format_type="issue">1</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 57-63</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3436401</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BE7XMZOQ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">biološki označevalci</subject><subject language_type_id="slv">farmakologija</subject><subject language_type_id="slv">klinična farmakologija</subject><subject language_type_id="slv">razvoj zdravil</subject><subject language_type_id="eng">security</subject><subject language_type_id="slv">toksikologija</subject><subject language_type_id="slv">varnost</subject><title>Biološki označevalci in njihova uporaba pri razvoju in zagotavljanju varnosti zdravil</title><title>Biomarkers and their use in drug safety assessment</title></Record>